ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Winter Conference & Expo
November 15–18, 2026
Phoenix, AZ|Arizona Grand Resort & Spa
Latest Magazine Issues
Aug 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
October 2026
Nuclear Technology
September 2026
Fusion Science and Technology
August 2026
Latest News
LLNL, Ampera partner to develop thorium-based TRISO fuel
Lawrence Livermore National Laboratory has formed a strategic partnership with Ampera to develop the company’s nuclear fuel concept through a project named THUNDER, for Thorium Unimodal Droplet Ejection for Reactors.
The focus of THUNDER is fabricating TRISO made with kernels of thorium rather than the usual uranium. LLNL and Ampera will evaluate and optimize liquid metal–jetting technology to produce highly uniform, spherical kernels of thorium-232 for later processing into TRISO fuel.
D. Lynn Shaeffer, F. Owen Hoffman
Nuclear Technology | Volume 45 | Number 1 | August 1979 | Pages 99-106
Technical Paper | Radioactive Waste | doi.org/10.13182/NT79-A32288
Articles are hosted by Taylor and Francis Online.
An analysis was made of the uncertainty in the prediction of dose to an individual’s thyroid due to the transport of radioactive molecular iodine, 131I2, from air through the pasture-cow-milk pathway. This analysis was facilitated by the adoption of a model consisting of a multiplication of several factors represented by lognormal distributions of values. Results indicate there is a 64, 50, or 23% chance of the annual dose to an individual’s thyroid not exceeding the mean, median, or most probable doses, respectively. However, these results are tentative as a result of the limited amount of data available for annual average dose assessments. The suggestion is made that consideration be given to adopting a probabilistic approach to determining an acceptable probability of an individual receiving a dose that exceeds a limiting value.